These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 4480070

  • 1. Toxicological studies of bucloxic acid (804 CB).
    Mazué G, Vallée E, Genet P, Navarro J, Brunaud M.
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1398-413. PubMed ID: 4480070
    [No Abstract] [Full Text] [Related]

  • 2. Study of possible teratogenicity of bucloxic acid (804 CB).
    Mazué G, Landsmann F, Brunaud M.
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1413-22. PubMed ID: 4480071
    [No Abstract] [Full Text] [Related]

  • 3. [A new nonsteroidal anti-inflammatory agent: bucloxic acid (804 CB)].
    Krausz F, Breliere JC, Vaillant J, Brunaud M, Navarro J.
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1364-7. PubMed ID: 4480065
    [No Abstract] [Full Text] [Related]

  • 4. Study of possible mutagenicity of bucloxic acid (804 CB).
    Mazué G, Vindel JA, Landsmann F, Brunaud M.
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1422-5. PubMed ID: 4614818
    [No Abstract] [Full Text] [Related]

  • 5. [Non-steroidal anti-inflammatory agents: derivatives of 4-phenylbutyric and 4-phenyl-4-oxobutyric acid].
    Krausz F, Demarne H, Vaillant J, Brunaud M, Navarro J.
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1360-4. PubMed ID: 4480064
    [No Abstract] [Full Text] [Related]

  • 6. Metabolic and pharmacokinetic study of bucloxic acid. I. Isolation and identification of the main excretion products in animals and in man.
    Gros PM, Davi HJ, Chasseaud LF, Hawkins DR.
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1385-90. PubMed ID: 4480068
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacologic properties of a new, nonsteroidal anti-inflammatory agent, bucloxic acid (804 CB)].
    Navarro J, Stoliaroff M, Savy JM, Berny C, Brunaud M.
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1368-78. PubMed ID: 4480066
    [No Abstract] [Full Text] [Related]

  • 8. Toxicological investigations of 4,5-diphenyl-2-bis(2-hydroxyethyl)-aminoxazol (ditazol or S 222).
    Caprino L, Borrelli F, Falchetti R.
    Arzneimittelforschung; 1973 Sep; 23(9):1287-91. PubMed ID: 4801222
    [No Abstract] [Full Text] [Related]

  • 9. Metabolic and pharmacokinetic study of bucloxic acid. II. Pharmacokinetic study in the baboon.
    Chasseaud LF, Fry BJ, Gros PM.
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1390-7. PubMed ID: 4480069
    [No Abstract] [Full Text] [Related]

  • 10. Toxicological and teratological studies of 4((5-chloro-2-oxo-3-benzothiazolinyl)acetyl)-1-piperazine ethanol hydrochloride (Tiaramide hydrochloride), an anti-inflammatory drug.
    Watanabe N, Takashima T, Ito N, Fujii T, Miyazaki K.
    Arzneimittelforschung; 1973 Apr; 23(4):504-8. PubMed ID: 4197071
    [No Abstract] [Full Text] [Related]

  • 11. [Toxicological study of the choleretic L-H-4,5,6,7-tetrahydro-2-benzyl-L-(morpholino-2-aminoethyl)-4,5-dimethyl-5,7-dioxo-imidazo-4,5-d-pyrimidine (AC 3092)].
    Georges A, Dusart P, Gerin Y, Denef J.
    Arzneimittelforschung; 1969 Jul; 19(7):1113-8. PubMed ID: 5395533
    [No Abstract] [Full Text] [Related]

  • 12. Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Subacute and chronic toxicity in rats and dogs.
    Gaetani M, Debeus R, Bonardi G, Coppi G.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:216+. PubMed ID: 5067196
    [No Abstract] [Full Text] [Related]

  • 13. [Introduction: Esfar (bucloxic acid, 804 CB)].
    Brunard M.
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1359. PubMed ID: 4480063
    [No Abstract] [Full Text] [Related]

  • 14. Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
    Lagrue G, Masbernard A, Giudicelli C, Hirbec G.
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1434-9. PubMed ID: 4614821
    [No Abstract] [Full Text] [Related]

  • 15. Acute, subacute and chronic toxicity of oxepinac.
    Nomura M, Onodera T, Kato M, Yamada A, Ogawa H, Akimoto T.
    Arzneimittelforschung; 1978 Sep; 28(3):445-51. PubMed ID: 580754
    [Abstract] [Full Text] [Related]

  • 16. [Toxicity of sodium bromide for animals].
    Shafirov IuB, Khovakh IM, Shamrova LD.
    Farmakol Toksikol; 1970 Sep; 33(5):620-2. PubMed ID: 5493225
    [No Abstract] [Full Text] [Related]

  • 17. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD.
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [Abstract] [Full Text] [Related]

  • 18. Toxicological investigation of 4-(p-chlorophenylthio)butanol (W-2719) administered orally to rats and dogs for 13 weeks.
    Sofia RD, Banerjee BN, Ivins NJ, Harakal JJ, Ludwig BJ.
    Arzneimittelforschung; 1979 Jul; 29(9):1382-9. PubMed ID: 583246
    [No Abstract] [Full Text] [Related]

  • 19. [Biological surveillance during a test of 804 CB in internal medicine. 120 observations].
    Gallais H, Casanova P.
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1442-4. PubMed ID: 4480073
    [No Abstract] [Full Text] [Related]

  • 20. Toxicological study on bamifylline.
    Georges A, Dusart P, Gerin Y, Denef J.
    Arzneimittelforschung; 1968 Apr; 18(4):460-6. PubMed ID: 5754939
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.